Socrates Said," Let foods be your medicine and let medicine be your foods". Let us all practice the values of the past wisdom to build a letter living and living health while we enjoy the delicious drinks

Wednesday, August 23, 2017

All About Vitamins: Vitamin B2 Reduced Risk of Acute Ischaemic Stroke and Improved Cognition in Post Stroke Patients

Kyle J. Norton(Scholar, Master of Nutrients), all right reserved.
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.

Intake of riboflavin (vitamin B2) supplementation may be beneficiary in prevent acute stroke, through reduced levels of oxidation, the respectable University stated.

Vitamin B2 also known as Riboflavin, is a water-soluble, yellow-orange organic compound found abundantly in milk, meat, eggs, nuts, enriched flour, green vegetables, etc. The vitamin is essential for normal cellular growth and function and best known for converting energy from protein, fat, and carbohydrates during metabolism and its antioxidant effects in oxidation-reduction reactions.

In the testing of vitamin B2 levels of a total of 96 acute ischaemic stroke patients, vitamin B2 deficiency is found in over 51% of the population.

According to the University of Sheffield, oral administrated 5 mg of oral riboflavin and other B-group vitamins within 12 h of the stroke onset and then daily or no B-vitamins for 14 days in these patients, vitamin B2 treated group expressed a significant improvement of status compared with the control group.

Dr. Gariballa S, the lead researcher said, "Seven out of 37 patients in the supplement group (19%) were riboflavindeficient compared with 22 out of 39 patients (56%) in the control group at the end of the treatment period" and "A high proportion of acute stroke patients were biochemically deficient of riboflavin immediately post-infarct".

Furthermore, in the total of included 35 patients aged 40-70 years with the newly diagnosed mild and moderate stroke, with main group comprised 29 patients treated with cytoflavin (10 ml twice daily by i/v drop infusion for 10 days), a conventional medicine containging inosine, vitamin B2, 3 and succinic acid, in addition to basal therapy with Controls (n=15) given basal therapy alone, treatment of conbination group displayed a significant improvement of short- and long-term memory as well as the highest health index in compared control.

In all patients examined on days 1 and 15, the onset of therapy revealed some positive dynamics. Indicators of functional normalization in groups 1, such as cognitive function (from the ability to remember 10 words), everyday activities, and quality of life (based on the QOL scale) than control group.

Dr. Shestakov VV, the abovestudy lead author indicated, " cytoflavin therapy significantly improved the health status of the patients. It proved efficacious as regards correction of motor and non-motor symptoms in patients having acuteischemic stroke".

Taking together, Vitamin B2 sumplement may have a potential in reduced risk of acute ischaemic stroke and improved cognitive function  in post stroke patients.

No comments:

Post a Comment